Eva Renee Barnett, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 6,062 shares at $29.64 ($180K) on 2024-07-17, disclosed to the SEC on 2024-07-19.
Open-market sale of $180k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.64 | 2,939 | $87K | 48.4% |
| 2 | $29.64 | 2,939 | $87K | 48.4% |
| 3 | $30.55 | 184 | $6K | 3.1% |
| Total | $29.67 avg | 6,062 | $180K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $117K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $107K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $198K | — | Filing → |